News
Expert speakers break down the science behind CAR cell therapy and T-cell engagers, explain the clinical trial process, and discuss potential benefits and risks. Whether you’re living with lupus, ...
CAR T cell therapy has exquisite selectivity for blood cancers— meaning it does a good job of only attacking cancer cells— and because it doesn't affect healthy cells, it doesn't cause the ...
They said that their findings will need to be tested and improved upon by further study, and they noted that their results arise from a clinical trial of one particular CAR T-cell product, which is ...
By designing the CAR T cells to look for cooperative signaling from two target antigens, we could keep the CAR T cell potency high while minimizing its damage to normal cells.” Dr. Sadelain’s team ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results